Showing 1 - 9 results of 9 for search 'Jingjing Hou', query time: 0.02s
Refine Results
-
1
Northern Shanghai Study II: systematic assessment and management of early organ damage and its role in preventing and reducing cardiovascular risk—protocol of a prospective study by Yi Zhang, Shikai Yu, Jun Han, Jingjing Hou, Moran Li, Xinming Jia, Fenyong Sun
Published 2023-12-01Get full text
Article -
2
-
3
-
4
Exploring the psychological impact of long COVID: symptoms, mechanisms, and treatments by Shi Shen, Xin Zhao, Jianxin Pei, Bijue Wang, Jingjing Hou, Ru Chai, Yiqiong Guo, Feiyu Li, Jian Hao, Zhonglan Wu
Published 2025-08-01Get full text
Article -
5
Association between novel Immune-Inflammatory markers and hypertension patients with coronary heart disease: A Cross-Sectional study based on NHANES (2005–2016) by Ruiyuan Li, Aili Atawula, Haonan Li, Moran Li, Jiamin Tang, Jie Liu, Jieying Shi, Jingjing Hou, Feng Hai, Yifan Zhao, Lipeng Guo
Published 2025-07-01Get full text
Article -
6
Study on sentinel hosts for surveillance of future COVID-19-like outbreaks by Yanjiao Li, Jingjing Hu, Jingjing Hou, Shuiping Lu, Jiasheng Xiong, Yuxi Wang, Zhong Sun, Weijie Chen, Yue Pan, Karuppiah Thilakavathy, Yi Feng, Qingwu Jiang, Weibing Wang, Chenglong Xiong
Published 2024-10-01Get full text
Article -
7
Retraction: Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers by Xuehui Hong, He Huang, Xingfeng Qiu, Zhijie Ding, Xing Feng, Yuekun Zhu, Huiqin Zhuo, Jingjing Hou, Jiabao Zhao, Wangyu Cai, Ruihua Sha, Xinya Hong, Yongxiang Li, Hongjiang Song, Zhiyong Zhang
Published 2025-06-01Get full text
Article -
8
RETRACTED: Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers by Xuehui Hong, He Huang, Xingfeng Qiu, Zhijie Ding, Xing Feng, Yuekun Zhu, Huiqin Zhuo, Jingjing Hou, Jiabao Zhao, Wangyu Cai, Ruihua Sha, Xinya Hong, Yongxiang Li, Hongjiang Song, Zhiyong Zhang
Published 2018-01-01Get full text
Article -
9
Screening and discovery of an antiviral candidate inhibiting the SARS-CoV-2 envelope (2-E) channel by Han Zhang, Shuxin Shi, Lujia Sun, Shuangqu Li, Yan Zhang, Ziyue Li, Jingjing Hou, Pingan Li, Jingshan Shen, Xi Cheng, Shibo Jiang, Zhaobing Gao, Xinling Wang, Xiangrui Jiang, Bingqing Xia
Published 2025-01-01Get full text
Article